Table 1.
Correlations between HKDC1 expression and clinicopathologic features
| Characteristic | HKDC1 expression | p value | |
|---|---|---|---|
| Low expression (%) | High expression (%) | ||
| Age | 0.681 | ||
| > 55 | 16 (30.77%) | 36 (69.23%) | |
| ≤ 55 | 6 (26.09%) | 17 (73.91%) | |
| Sex | 0.302 | ||
| Male | 10 (24.39%) | 31 (75.61%) | |
| Female | 12 (35.29%) | 22 (64.71%) | |
| Tumor location | 0.428 | ||
| Left lung | 9 (25.00%) | 27 (75.00%) | |
| Right lung | 13 (33.33%) | 26 (66.67%) | |
| Histologic differentiation | 0.003 | ||
| Well + moderate | 20 (40.82%) | 29 (59.18%) | |
| Poor | 2 (7.69%) | 24 (92.31%) | |
| Pathological T stage | 0.627 | ||
| T1–2 | 15 (31.25%) | 33 (68.75%) | |
| T3–4 | 7 (25.93%) | 20 (74.07%) | |
| Pathological N stage | 0.009 | ||
| N0 | 16 (43.24%) | 21 (56.76%) | |
| N+ | 6 (15.79%) | 32 (84.21%) | |
| TNM stage | 0.843 | ||
| I + II | 13 (30.23%) | 30 (69.77%) | |
| III + IV | 9 (28.13%) | 23 (71.87%) | |